Status:
COMPLETED
Microvascular Function in Patients Undergoing 5-Fluorouracil Chemotherapy
Lead Sponsor:
Kansas State University
Conditions:
Gastrointestinal Cancer
Head and Neck Cancer
Eligibility:
All Genders
21+ years
Brief Summary
The primary aim of this study is to investigate potential differences in vascular function between patients receiving 5-Fluorouracil (5-FU) chemotherapy, patients receiving chemotherapies other than 5...
Detailed Description
Although cancer continues to be one of the leading causes of death each year, advancements in cancer treatments and detection have improved patient prognosis across a large number of cancer types. Thi...
Eligibility Criteria
Inclusion
- Give voluntary consent to participate in the study
- (Group 1) Current cancer treatment includes 5-FU
- (Group 2) Current cancer treatment does not include 5-FU
- (Group 3) Cancer survivor previously treated with 5-FU but has not received cancer treatment in the year proceeding enrollment.
- (Group 4) Age, sex, and health matched (excluding cancer) control for Group 1
Exclusion
- (Groups 1, 2, and 4) Have received cancer treatment outside of the past year
- Not met above criteria
- Pregnant, breastfeeding, or planning to become pregnant
- Unable to provide informed consent
Key Trial Info
Start Date :
June 25 2019
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 1 2023
Estimated Enrollment :
62 Patients enrolled
Trial Details
Trial ID
NCT04042298
Start Date
June 25 2019
End Date
June 1 2023
Last Update
September 2 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Lafene Health Center
Manhattan, Kansas, United States, 66502